Phenytoin is a commonly prescribed
antiepileptic drug. Due to its saturation (zero-order) pharmacokinetics,
phenytoin carries a special risk of dose-related toxicity that is an important issue in emergency medicine. The purpose of this cross-sectional case-series study was to investigate the causes, symptoms, misdiagnoses, and outcomes of acute
phenytoin intoxication. It was based on a retrospective chart review of 30 inpatients (mean age, 41.6 +/- 22.8 years) with 36 episodes of acute
phenytoin intoxication at our university hospital in the past 13 years. The average initial serum
phenytoin level was 47.3 +/- 9.7 microg/mL (range, 27.9-70.4 microg/mL). Excessive
self-medication, misunderstanding of the prescription order, and probable drug interaction were the three leading causes of acute
phenytoin intoxication.
Unsteady gait,
dizziness/
vertigo,
nausea/
vomiting, general weakness, and drowsiness were the most common presenting symptoms. The tentative diagnostic accuracy was 67%. The most common initial misdiagnosis was brainstem or cerebellum
stroke (14%). The
clinical course in all patients was uneventful under temporary withdrawal of
phenytoin and supportive care. We concluded that acute
phenytoin intoxication was relatively under-diagnosed in the emergency service. Although acute
phenytoin intoxication causes no mortality and has a good outcome, the
unsteady gait increases the risk of
injuries caused by falls. The management of acute
phenytoin intoxication includes temporary withdrawal of
phenytoin and supportive care.